HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

mixanpril

a lipophilic prodrug of RB 105; structure given in first source

Also Known As:

L-Alanine, N-(2-((benzoylthio)methyl)-1-oxo-3-phenylbutyl)-, (S-(R*,S*))-

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Amino Acids: 30675
  - Alanine: 4133
    - mixanpril: 3

Experts

1.	Arbin, Valérie: 1 article (02/2003)
2.	Claperon, Nicole: 1 article (02/2003)
3.	Fournié-Zaluski, Marie-Claude: 1 article (02/2003)
4.	Peyroux, Jacques: 1 article (02/2003)
5.	Roques, Bernard P: 1 article (02/2003)
6.	Arbin, V: 1 article (06/2001)
7.	Claperon, N: 1 article (06/2001)
8.	Fournié-Zaluski, M C: 1 article (06/2001)
9.	Peyroux, J: 1 article (06/2001)
10.	Roques, B P: 1 article (06/2001)

Related Diseases

1.	Insulin Resistance 02/01/2003 - "Effects of dual angiotensin-converting enzyme and neutral endopeptidase 24-11 chronic inhibition by mixanpril on insulin sensitivity in lean and obese Zucker rats." 06/01/2001 - "Acute effect of the dual angiotensin-converting enzyme and neutral endopeptidase 24-11 inhibitor mixanpril on insulin sensitivity in obese Zucker rat."
2.	Hypertension (High Blood Pressure) 04/26/1994 - "Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase by the orally active inhibitor mixanpril: a potential therapeutic approach in hypertension."

Related Drugs and Biologics

1.	Neprilysin (Neutral Endopeptidase)
2.	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)